Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: BMS Looks To Molecular Templates’ Engineered Toxin Bodies In Cancer

DealWatch_1200x675

Related Content

Sandoz Strikes $500m Deal For GSK Cephalosporins

Feb 11 2021

Lannett Adds NovoLog Biosimilar As It Writes Off $198m Of Value

Feb 10 2021

Hyloris And Purna Strike Value-Added Development Deal

Sep 19 2025

Merck & Co Puts A Date On Spinning Off Biosimilars

Feb 05 2021

Threshold And Molecular Templates Merge To Test The Power Of Two

Mar 17 2017

Deal Watch: Molecular Templates Aligns With Vertex On Optimizing Stem Cell Candidates

Nov 22 2019

Venture Funding Deals: Orchard Brings Total To $291m

Sep 07 2018

Ensoma Launches With Takeda Partnership On Myeloablation-Free Gene Therapy

Feb 11 2021

Avacta/Daewoong’s Joint-Venture AffyXell Paves Way For Next-Generation Stem Cell Therapy

Feb 11 2021

Sanofi Upbeat On Itepekimab, Rilzabrutinib And Oral IRAK4 Protein Degrader

Feb 10 2021

Genmab Commercial Expansion Opens The Door To New Types Of Deals

Feb 09 2021

Related Companies

Bristol Myers Squibb Company

Molecular Templates, Inc.

Threshold Pharmaceuticals, Inc.

Takeda Pharmaceutical Co. Ltd.

Vertex Pharmaceuticals Incorporated

AbbVie Inc.

Caribou Biosciences, Inc.

Sanofi

i2O Therapeutics, Inc.

Merck & Co., Inc.

Starpharma Holdings Limited

Protalix BioTherapeutics, Inc.

SarcoMed USA

Circio Holding ASA

Papyrus Therapeutics, Inc.

Medivir AB

Ubiquigent Limited

Eton Pharmaceuticals, Inc.

Azurity Pharmaceuticals, Inc.

Additional Topics

Deals M & A Business Strategies Commercial BioPharmaceutical

More from Deals

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window